Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

familial prostate carcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

familial prostate carcinoma

MONDO:0023122

Also known as:hereditary prostate carcinomaprostate cancer, familialprostate cancer, hereditary

Find Clinical TrialsTrials

Overview

Prostate carcinoma that has developed in relatives of patients with a history of prostate carcinoma.

Clinical Trials4 registered

ResearchLimited published research (7 articles)

Diagnosis

Biomarker and diagnostic research for familial prostate carcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

4 clinical trials registered. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE2, 2 NA. Research is primarily sponsored by academic and government institutions.

7 publications have been identified in PubMed for familial prostate carcinoma. Research spans Basic Science / Preclinical (29%), Diagnostic / Biomarker (14%), and Review / Meta-Analysis (14%).

Recent Publications

Michaelson-Cohen R (2026). [PMID: 41612487](https://pubmed.ncbi.nlm.nih.gov/41612487/). *Isr J Health Policy Res*. [Diagnostic / Biomarker]
Aoki M (2025). [PMID: 40295048](https://pubmed.ncbi.nlm.nih.gov/40295048/). *Anticancer Res*. [Epidemiology / Natural History]
Dupont WD (2025). [PMID: 39874495](https://pubmed.ncbi.nlm.nih.gov/39874495/). *JCO Precis Oncol*. [Basic Science / Preclinical]
Byrne L (2025). [PMID: 40533153](https://pubmed.ncbi.nlm.nih.gov/40533153/). *J Med Genet*. [Clinical Trial Publication]
Kwong A (2025). [PMID: 40805222](https://pubmed.ncbi.nlm.nih.gov/40805222/). *Cancers (Basel)*. [Basic Science / Preclinical]

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 4:43 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:4520

Questions for Your Care Team

→Are any of the 4 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

familial prostate carcinoma

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

GARD

Questions for Your Care Team

Questions for Your Care Team

Latest News & Developments

Peribronchial cuffing: an underrecognized pattern of prostate carcinoma metastases to the lung.

The role of multimodal imaging in diagnosis in the diagnosis of epididymal metastasis from prostate carcinoma: A case report.

familial prostate carcinoma

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Latest News & Developments

Peribronchial cuffing: an underrecognized pattern of prostate carcinoma metastases to the lung.

The role of multimodal imaging in diagnosis in the diagnosis of epididymal metastasis from prostate carcinoma: A case report.